Seven Fleet Partners LP 13D/13G Filings for CytomX Therapeutics, Inc. (CTMX)

Seven Fleet Partners LP 13D and 13G filings for CytomX Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-20
9:02 pm
Purchase
2025-05-13 13G CytomX Therapeutics, Inc.
CTMX
Seven Fleet Partners LP 377,161
0.200%
377,161increase
(New Position)
Filing